RxDoctor Payments Data

Rita Shah

Primary Care · Clinton Township, MINPI 1487265559

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Medtronic at 27.7% of the total.

$1,897in general payments, 2019–2025

Across 89 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$525
  • Novo Nordisk$249
  • Xeris Pharmaceuticals, Inc.$137
  • Lilly USA, LLC$131
  • Amgen$122
  • Boehringer Ingelheim$97
  • plus $636 from 15 others

What the payments were for

  • Travel & lodging$392%
  • Food & beverage$1,85898%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,897 in reported general payments places this provider in the 80th percentile of 292 primary care providers in Michigan.

See all primary care providers in Michigan

Medicare billing

Part B allowed, 2024
$3,826
Medicare patients
22
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate14$737
Atorvastatin Calcium11$157
Levothyroxine Sodium11$50
Azithromycin11$38

Paid to pharmacies, not to this prescriber.

Other primary care in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →